充血性心衰应用冻干重组人脑利钠肽治疗的疗效及安全性评价
2015-01-31卞野赵春生杜杰
卞野 赵春生 杜杰
充血性心衰应用冻干重组人脑利钠肽治疗的疗效及安全性评价
卞野1赵春生2杜杰1
【摘要】目的研究冻干重组人脑利钠肽治疗充血性心衰的疗效和安全性。方法 选择我院收治的102例充血性心衰患者为研究对象,随机分为两组,其中给予对照组常规治疗,观察组则运用冻干重组人脑利钠肽治疗,对比分析两组的疗效。结果 观察组的治疗总有效率高于对照组,P<0.05,差异具有统计学意义。结论 临床上运用冻干重组人脑利钠肽治疗充血性心衰,可以获得较好的效果。
【关键词】充血性心衰;新活素;疗效
作者单位:1 136000吉林省四平市中心医院心内科;2 136000吉林省四平市妇婴医院妇产科
Safety Evaluation and Curative Effect of Congestive Heart Failure Application on Lyophilization Recombinant Human Brain Batriuretic
BIAN Ye1ZHAO Chunsheng2DU Jie11 Siping City The Central Hospital Cardiology Department in Jilin Province, Siping 136000, China. 2 Siping City Sleeper Davis Hospital Gynaecology and Obstetrics Department, Siping 136000, China
[Abstract]Objective To explore the treatment of congestive heart failure to use the new fuel. Methods Selected 102 cases of patients with congestive heart failure in our hospital as the research object, and randomly divided into two groups, which give the control group routine treatment, the observation group to used new fuel treatment, compared two groups of curative effect. Results The total effective rate of observation group was higher than the control group, P<0.05, had difference statistically significance. Conclusion The clinical use of new active element in the treatment of congestive heart failure, can obtain good effect.
[Key words]Congestive heart failure, New living element, Curative effect
心力衰竭是比较常见的一种心血管疾病,主要由于功能性疾病或者心脏结构使心室射血和充盈能力受损而导致的一种综合征,在临床上表现为液体潴留、乏力以及呼吸困难等症状,好发于中老年人,对患者的身体健康和生活质量造成影响[1]。当前临床上在治疗充血性心衰时,通常以对症治疗为主,但是疗效不高。探讨充血性心衰运用冻干重组人脑利钠肽治疗的临床效果,具体报道如下。
1 资料和方法
1.1一般资料
选择我院收治的102例充血性心衰患者为研究对象,随机分为两组,每组51例。对照组中男性31例,女性20例,年龄35~80岁,平均年龄为(65.65±9.42)岁,其中31例为冠心病,10例为风湿性心脏病,10例为高血压性心脏病;观察组中男性30例,女性21例,年龄36~81岁,平均年龄为(65.73±9.51)岁,其中28例为冠心病,12例为风湿性心脏病,11例为高血压性心脏病。……
